Company / SG&A per Share
Elanco SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.88
FY2025
5-year range
$2.61 / $2.97
FY2021-FY2025
Trend
+8.3%
vs FY2024
Sector context
#66 of 210
Health Care
What the data says
At $2.88, Elanco's sg&a per share ranks #145 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $2.01 in FY2018 to $2.97 in FY2021.
Based on SEC 10-K filings.
2.88 in FY2025 with a 5-year CAGR of +1.5%.
Increased from $2.61 to $2.88 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +2.6%
- 5-Year CAGR
- +1.5%
- 10-Year CAGR
- -
Sector benchmark
#145 of 210 in Health CareTop 69% of 210This company $2.88 Sector average $40.75
▼
-92.9% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 8.3% year-over-year.
- Ranks #66 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2021.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.88 | +8.3% |
| FY2024 | $2.66 | +1.9% |
| FY2023 | $2.61 | -2.3% |
| FY2022 | $2.67 | -10.3% |
| FY2021 | $2.97 | +11.2% |
| FY2020 | $2.67 | +28.6% |
| FY2019 | $2.08 | +3.4% |
| FY2018 | $2.01 | -24.4% |
| FY2017 | $2.66 | -0.6% |
| FY2016 | $2.68 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026